The cost of squamous cell cancer of the head and neck is driven primarily by the end-of-life phase. Treatment costs increased following the approval of cetuximab.
Christopher R. Frei, PharmD, MS
Advertisement
Articles by Christopher R. Frei, PharmD, MS
Advertisement
Latest Updated Articles
- Cost of Squamous Cell Cancer of the Head and Neck
Published: June 22nd 2017 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Expert Discusses Logistical Considerations and Future Research Needs for Radiopharmaceuticals
2
A Common Virus May Hold New Clues to Lupus
3
Zongertinib Shows Clinically Meaningful Efficacy in Advanced HER2-Mutant NSCLC
4
SHR-A1811 Plus Pertuzumab Improves Survival in HER2-Positive Metastatic Breast Cancer
5
